BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.510
-0.005 (-0.33%)
At close: May 31, 2024, 4:00 PM
1.460
-0.050 (-3.31%)
After-hours: May 31, 2024, 5:42 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $72.66 million as of May 31, 2024. Its market cap has decreased by -54.90% in one year.
Market Cap
72.66M
Enterprise Value
-6.05M
1-Year Change
-54.90%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $72.66M, a decrease of -87.42%. That is a compound annual growth rate of -45.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2024 | 72.90M | -0.27% |
| May 29, 2024 | 73.10M | -9.53% |
| May 28, 2024 | 80.80M | -1.82% |
| May 24, 2024 | 82.30M | -18.51% |
| May 23, 2024 | 101.00M | -7.93% |
| May 22, 2024 | 109.70M | -2.14% |
| May 21, 2024 | 112.10M | -5.08% |
| May 20, 2024 | 118.10M | -13.29% |
| May 17, 2024 | 136.20M | -8.71% |
| May 16, 2024 | 149.20M | 3.40% |
| May 15, 2024 | 144.30M | 14.89% |
| May 14, 2024 | 125.60M | -1.10% |
| May 13, 2024 | 127.00M | -2.53% |
| May 10, 2024 | 130.30M | -6.93% |
| May 9, 2024 | 140.00M | -6.98% |
| May 8, 2024 | 150.50M | 1.28% |
| May 7, 2024 | 148.60M | -2.56% |
| May 6, 2024 | 152.50M | -2.43% |
| May 3, 2024 | 156.30M | 2.83% |
| May 2, 2024 | 152.00M | -6.23% |
| May 1, 2024 | 162.10M | 49.40% |
| Apr 30, 2024 | 108.50M | -12.57% |
| Apr 29, 2024 | 124.10M | 1.55% |
| Apr 26, 2024 | 122.20M | 12.94% |
| Apr 25, 2024 | 108.20M | -4.25% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 75.12M |
| Aclaris Therapeutics | 74.83M |
| MDxHealth | 74.50M |
| HeartBeam | 74.25M |
| Burning Rock Biotech | 73.24M |
| Tempest Therapeutics | 72.87M |
| HOOKIPA Pharma | 72.58M |
| Allurion Technologies | 72.40M |